Jump Financial, LLC Cue Biopharma, Inc. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Oct 21, 2024
BUY
$3.11 - $4.91 $133,419 - $210,639
42,900 New
42,900 $156,000
Q2 2023

Aug 07, 2023
BUY
$3.11 - $4.91 $133,419 - $210,639
42,900 New
42,900 $156,000
Q4 2022

Feb 13, 2023
BUY
$2.39 - $3.95 $27,788 - $45,926
11,627 New
11,627 $33,000
Q2 2022

Aug 09, 2022
BUY
$2.49 - $5.92 $24,890 - $59,176
9,996 Added 39.51%
35,296 $88,000
Q1 2022

May 12, 2022
BUY
$4.41 - $12.28 $111,573 - $310,684
25,300 New
25,300 $123,000

Others Institutions Holding CUE

# of Institutions
52
Shares Held
14.1M
Call Options Held
14.4K
Put Options Held
2.6K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $38.2M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email